Shangxin Capital key facts
- Shangxin Capital is a other based in Shanghai, China with 1 tracked portfolio company.
- Notable positions include Trinomab(Zhuhai).
About Shangxin Capital
Shangxin Capital is a venture capital firm headquartered in Shanghai, China. Established in 2014, the firm seeks to make investments into life science and medical technology companies. The assets of the firm are managed and governed by an executive management team.
Shangxin Capital portfolio at a glance
1 portfolio company is on record for Shangxin Capital: Trinomab(Zhuhai).
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·Watchlist + alerts for Shangxin Capital's activity
Portfolio
1 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Trinomab(Zhuhai) | — | ▮ | ▮ | ▮ |
All 1 companies — valuations, dates and lead flags are a member feature Membership and data by Private Market View | ||||
Frequently asked about Shangxin Capital
- What companies does Shangxin Capital invest in?
- Shangxin Capital has 1 recorded portfolio companies, including Trinomab(Zhuhai).
- What is Shangxin Capital's AUM?
- Shangxin Capital manages approximately $1K in assets.